[REGN] QoQ Quarter Result on 31-Mar-2012 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
26-Apr-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- 121.80%
YoY- 126.82%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 414,602 427,687 304,399 231,789 122,977 102,833 107,810 144.46%
PBT 134,559 191,468 76,743 11,651 -54,058 -61,803 -63,368 -
Tax -335,848 -517 -501 -610 -615 562 -863 5134.86%
NP 470,407 191,468 76,743 11,651 -53,443 -62,365 -62,505 -
Tax Rate 249.59% 0.27% 0.65% 5.24% - - - -
Total Cost -55,805 236,219 227,656 220,138 176,420 165,198 170,315 -
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 113.46 44.77 25.21 5.03 -43.46 -60.65 -57.98 -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
EPS 4.92 2.02 0.81 0.12 -0.58 -0.68 -0.69 -
EPS Diluted 4.26 1.72 0.70 0.11 -0.57 -0.68 -0.69 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.